Weed (BUDZ) EPS (Basic) Growth (3y) (2020 - 2026)
Weed (BUDZ) EPS (Basic) Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 3.18% |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | 2.42% |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 12.25% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -35.06% |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 13.47% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 36.60% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Weed | 3.13 Mn | 3.13 Mn | - | 15.79% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.99% |
| Dec 31, 2025 | -121.40% |
| Sep 30, 2025 | 70.97% |
| Jun 30, 2025 | 67.50% |
| Mar 31, 2025 | 49.38% |
| Dec 31, 2024 | 35.53% |
| Sep 30, 2024 | 21.16% |
| Jun 30, 2024 | 56.33% |
| Mar 31, 2024 | 45.51% |
| Dec 31, 2023 | -22.57% |
| Sep 30, 2023 | 71.30% |
| Jun 30, 2023 | -84.18% |
| Mar 31, 2023 | 61.61% |
| Dec 31, 2022 | 61.33% |
| Sep 30, 2022 | 24.90% |
| Jun 30, 2022 | 27.70% |
| Mar 31, 2022 | 36.11% |
| Dec 31, 2021 | 61.38% |
| Sep 30, 2021 | 72.22% |
| Jun 30, 2021 | 51.36% |